Novel Energy Metabolic Signaling Molecule With Therapeutic Potential
Clinical trial NCT04713319 · COMPLETED
Trial details
- NCT number
- NCT04713319
- Sponsor
- Petteri Hirvonen
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2021-12-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.